RiceBran Technologies (RIBT)

[coyle52]

This is a good oldie also.


NUTRASTAR PATENT CLAIMS STABILIZED RICE BRAN MAY HELP 35 MILLION DIABETICS
BY LOWERING BLOOD GLUCOSE LEVELS
November 4, 2002
>From a press release
EL DORADO HILLS, Calif.-- NutraStar(TM) Incorporated (OTC Bulletin Board:
NTRA) (Berlin: NTQ) announced today that a double-blind cross-over study,
which was published in the March 2002 issue of the Journal of Nutritional
Biochemistry and resulted in the issuance of U.S. Patent No. 6,126,943 may
hold a key for millions of people who are fighting diabetes I and II by
helping to control blood glucose levels.
(Photo: http://www.newscom.com/cgi-bin/prnh/20020603/NUTRASTARLOGO )
"The data from this clinical trial indicates that supplementing the diet
with products derived from specially processed stabilized rice bran
derivatives may help lower blood sugar levels in both Type I and Type II
diabetics by as much as 30%," said Dr. Barbara Levine, Director of the Human
Nutrition Program at Cornell Medical College and Rockefeller University.
"This is a significant finding in view of the short duration of the study,"
said Dr. Asaf Qureshi, chief investigator of the study. "One out of four
diabetics in the 57-subject study lowered their daily dosage of medication
by 30%-60% just by adding these special stabilized rice bran derivatives,
RiSolubles(R) and RiceMucil(R), to their daily diet. While not all of the
subjects were able to reduce their hyperglycemic medications, all of the
subjects were able to maintain a lower blood glucose level on these regimens
as compared to their respective placebo groups."
Dr. Qureshi and his colleagues at Advanced Medical Research in Madison,
Wisconsin found that by consuming 20 grams per day of either RiSolubles(R)
or RiceMucil(R) for 60 days, both Type I and Type II diabetics were able to
lower their blood sugar levels by 30% and 20%, respectively.
"In addition, the study also found that the stabilized rice bran derivatives
were able to lower total serum cholesterol and total triglyceride levels
between 5% and 15% in subject with marginally elevated cholesterol. "Not
only was there a decrease in blood glucose levels," said Levine, "but there
was also a lowering of the serum lipid parameters in these diabetic
patients."
NutraStar(TM) is the exclusive world-wide licensee of the rights to U.S.
Patent Number 6,126,943, issued on October 16, 2001. The patent is held by
The RiceX Company (OTC Bulletin Board: RICX), the exclusive manufacturer of
the stabilized rice bran derivatives, which were used in the study. RiceX
and NutraStar jointly prosecuted the patent entitled "A Method for Treating
Hyperglycemia, Hypoglycemia and Diabetes."
NutraStar(TM) Incorporated is emerging as a pioneering, science-based growth
company. NutraStar is focused on becoming the world's leading nutraceutical
company through the development and distribution of its proprietary
stabilized rice bran "super foods", natural arthritic relief products for
humans and animals and "all natural" cosmeceuticals and beauty aids. The